Related Experiment Video

Updated: Jun 10, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

CKD patients: the dilemma of serum PTH levels

Giuseppe Pontoriero1, Mario Cozzolino, Francesco Locatelli

  • 1Department of Nephrology and Dialysis, Ospedale Alessandro Manzoni, Lecco, Italy. g.pontoriero@ospedale.lecco.it

Nephron. Clinical Practice
|July 20, 2010
PubMed

Insights

Even small increases in parathyroid hormone (PTH) in early chronic kidney disease (CKD) raise cardiovascular risk. Early monitoring and management of mineral metabolism disorders are crucial for CKD patients.

Area of Science:

  • Nephrology
  • Endocrinology
  • Cardiovascular Medicine

Background:

  • Observational studies link elevated parathyroid hormone (PTH) to cardiovascular risk in stages 3-5 chronic kidney disease (CKD) not on dialysis.
  • This association persists irrespective of serum calcium, phosphorus, or vitamin D therapy.
  • Early detection and management of mineral metabolism disorders are vital to prevent excessive PTH secretion.

Purpose of the Study:

  • To highlight the importance of monitoring PTH levels from early CKD stages.
  • To address the challenges in determining when PTH suppression is needed due to variable patient responses.
  • To emphasize the need for adequate PTH target ranges and effective treatment strategies in CKD.

Main Methods:

  • Review of recent observational studies on CKD patients.
  • Analysis of the relationship between PTH levels and cardiovascular risk.
  • Discussion of limitations in current PTH assays and their predictive value for bone turnover.

Main Results:

  • Slight increases in PTH correlate with increased cardiovascular risk in early-stage CKD.
  • PTH levels alone may not accurately predict bone turnover.
  • Current PTH assays have methodological limitations.

Conclusions:

  • Close monitoring of PTH is recommended from the early stages of CKD.
  • Preventing mineral metabolism disorders is key to managing PTH levels.
  • Establishing adequate PTH target ranges and treatment strategies is crucial for mitigating cardiovascular complications in CKD.

More Related Videos

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...